1044733-65-4 Usage
Uses
Given the limited information provided, the potential uses of 3-(6-Bromopyridin-2-yl)-6-chloroimidazo[1,2-a]pyridine can only be hypothesized based on its chemical characteristics:
Used in Chemical Research:
3-(6-Bromopyridin-2-yl)-6-chloroimidazo[1,2-a]pyridine is used as a subject of study in chemical research for its unique molecular structure and potential to exhibit novel properties or reactivity.
Used in Organic Synthesis:
As a heterocyclic compound with multiple heteroatoms, 3-(6-Bromopyridin-2-yl)-6-chloroimidazo[1,2-a]pyridine is used as a building block or intermediate in the synthesis of more complex organic molecules, particularly those with potential pharmaceutical or material science applications.
Used in Medicinal Chemistry:
The presence of bromine and chlorine in the compound suggests that 3-(6-Bromopyridin-2-yl)-6-chloroimidazo[1,2-a]pyridine could be used in medicinal chemistry as a precursor or modifier for the development of new drugs, leveraging its ability to form halogen bonds or participate in other types of molecular interactions.
Check Digit Verification of cas no
The CAS Registry Mumber 1044733-65-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,4,4,7,3 and 3 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1044733-65:
(9*1)+(8*0)+(7*4)+(6*4)+(5*7)+(4*3)+(3*3)+(2*6)+(1*5)=134
134 % 10 = 4
So 1044733-65-4 is a valid CAS Registry Number.
1044733-65-4Relevant academic research and scientific papers
IRAK-4 inhibitors. Part III: A series of imidazo[1,2-a]pyridines
Buckley, George M.,Fosbeary, Richard,Fraser, Joanne L.,Gowers, Lewis,Higueruelo, Alicia P.,James, Lynwen A.,Jenkins, Kerry,Mack, Stephen R.,Morgan, Trevor,Parry, David M.,Pitt, William R.,Rausch, Oliver,Richard, Marianna D.,Sabin, Verity
scheme or table, p. 3656 - 3660 (2009/04/10)
Following the identification of a potent IRAK inhibitor through routine project cross screening, a novel class of IRAK-4 inhibitor was established. The SAR of imidazo[1,2-a]pyridino-pyridines and benzimidazolo-pyridines was explored.
